Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Changes in Apolipoprotein A1-Associated Proteomic Composition After Pioglitazone Treatment Versus Weight Loss

Changes in Apolipoprotein A1-Associated Proteomic Composition After Pioglitazone Treatment Versus Weight Loss

Authors: Parsa S, Collier TS, McPhaul MJ, Melander O, Knowles JW, Rohatgi A, Abbasi F

Citation: Int J Mol Sci. 2025 Nov 3;26(21):10690. doi: 10.3390/ijms262110690

Specialties: Endocrinology, Cardiology, Cardiovascular

Related content

Audio Podcast
Instant Insights: Apolipoprotein B
Audio Podcast
Instant Insight: Metabolic Risk Panel
On-Demand Webinar
Utilizing Apolipoprotein B in Cardiovascular Risk Assessment
Audio Podcast
Instant Insights: Lipoprotein Fractionation for Personalized Risk Assessment
Publication
Weight Loss Before Conception: Effects on Atherogenic Apolipoprotein Lipid Particles and Endothelial Function During Pregnancy
Publication
An HDL Proteomic Score Independently Predicts Incident Atherosclerotic Cardiovascular Disease
Conference Presentation
Pioglitazone Improves Apolipoprotein A1-Associated Proteomic Composition More Than Weight Loss in Insulin Resistance
Test FAQ
Cardio IQ® Lipoprotein Fractionation Ion Mobility
Publication
Biomarkers of Glucose-Insulin Homeostasis and Incident Type 2 Diabetes and Cardiovascular Disease: Results From the Vitamin D and Omega-3 Trial
Publication
Comparing ARR Versus Suppressed PRA as Screening Tests for Primary Aldosteronism

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.